Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-y1] butanamide----1件: 309 💬
2(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide----1件: 309 💬
3[Paracetamolo]----4件: 14, 19, 300, 309 💬
4[VAL-1221]----1件: 309 💬
5Brivaracetam1件: Brivaracetam1件: Brivaracetam 💬 1件: SV2A 💬 1件: ECM-receptor interaction 💬2件: 149, 309 💬
6Brivaracetam 25 mg1件: Brivaracetam1件: Brivaracetam 💬 1件: SV2A 💬 1件: ECM-receptor interaction 💬1件: 309 💬
7Brivaracetam 50 mg1件: Brivaracetam1件: Brivaracetam 💬 1件: SV2A 💬 1件: ECM-receptor interaction 💬1件: 309 💬
8BRV 2.5 mg----1件: 309 💬
9BRV 25 mg----1件: 309 💬
10BRV 50 mg----1件: 309 💬
11Cetirizina1件: Cetirizine2件: Cetirizine hydrochloride ,
Cetirizine 💬
1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬3件: 13, 300, 309 💬
12Clervonafusp alfa1件: Clervonafusp alfa1件: Clervonafusp alfa 💬 2件: GAA,
SLC29A2 💬
4件: Alcoholism, Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬1件: 309 💬
13Genetic: ION2831件: ION283---1件: 309 💬
14Intravenous Immunoglobulin----9件: 13, 14, 35, 38, 39, 49, 51, 63, 309 💬
15ION2831件: ION283---1件: 309 💬
16Itraconazole1件: Itraconazole1件: Itraconazole 💬 --13件: 2, 3, 6, 46, 65, 67, 96, 97, 137, 158, 227, 299, 309 💬
17J06BA02----1件: 309 💬
18PARACETAMOLO----10件: 2, 11, 14, 19, 28, 53, 61, 63, 300, 309 💬
19REQUIP----2件: 6, 309 💬
20ROPINIROLE1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬
3件: DRD2,
DRD3,
DRD4 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 74, 309 💬
21Ropinirole Hydrochloride1件: Ropinirole2件: Ropinirole hydrochloride ,
Ropinirole 💬
3件: DRD2,
DRD3,
DRD4 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 309 💬
22Ucb 34714----1件: 309 💬
23VAL-1221----2件: 256, 309 💬
24VENITAL - 50 G/L SOLUZIONE PER INFUSIONE FLACONCINO DA 100 ML + SET INFUSIONALE----1件: 309 💬